Real-world Evidence from a Cluster Survey of Patients Guided by Multi-center Dermatologists toward the Philippine Psoriasis Registry
Open Access
- 1 November 2024
- journal article
- Published by Wolters Kluwer Health in Journal of the Philippine Dermatological Society
- Vol. 33 (2) , 39-46
Abstract
Background: Psoriasis (PsO) is characterized by a chronic relapsing course with mild, moderate, or severe presentations associated with significant physical, mental, emotional, and socioeconomic burdens. To help the patients living with this condition, health agencies, lawmakers, and other stakeholders need accurate information generated from real-world data (RWD). Objective: The objective of this study was to derive RWD on demography, disease severity, comorbidities, and treatment regimens utilized by Filipino PsO patients. Methods: This prospective noninterventional study collects data from patients with PsO, screened and diagnosed by Philippine Dermatological Society-certified dermatologists through answering the Philippine Psoriasis Registry (PPR) questionnaires. Results: Answers by 780 participants to 9 specific questions from demographics to unmet needs at dermatology and rheumatology consultations were tabulated. A majority of patients (86.53%) had moderate-to-severe PsO, and only a few (8.72%) utilized the more effective medications due to socioeconomic factors of the underserved. Conclusions: The RWD from this PPR captures a snapshot of the PsO population within the Philippines. This is beneficial for understanding the current state of the population and explores disease progression and efficacy of interventions over time. Information sharing for future research through the strategic dissemination of findings from this study is imperative to enhance the understanding of PsO and its management on both local and global scales.Keywords
This publication has 12 references indexed in Scilit:
- Epidemiological analysis of the patients with psoriasis in Asian countries and region using the same clinical case cards between 2020 and 2022The Journal of Dermatology, 2024
- Lifetime risk, life expectancy, loss-of-life expectancy, and lifetime healthcare expenditures for psoriasis in Taiwan: a nationwide cohort followed from 2000 to 2017Therapeutic Advances in Chronic Disease, 2023
- National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling studyBMJ, 2020
- Trial designs using real‐world data: The changing landscape of the regulatory approval processPharmacoepidemiology and Drug Safety, 2019
- Review of European registries for psoriasisJournal of Dermatological Treatment, 2018
- Registries as real‐world cohort studies that are useful and necessary in the pyramid of evidenceBritish Journal of Dermatology, 2017
- Review of U.S. registries for psoriasisJournal of Dermatological Treatment, 2017
- Comment on “Review of patient registries in dermatology”Journal of the American Academy of Dermatology, 2016
- Psoriasis registries worldwide: systematic overview on registry publicationsJournal of the European Academy of Dermatology and Venereology, 2016
- National Registries of Systemic Treatment for Psoriasis and the European ‘Psonet’ InitiativeDermatology, 2008